TickerFactsScreenerDevelopers

Keros Therapeutics, Inc. (KROS) — Revenue

Annual figures by fiscal year, from SEC filings.

2019: $10.00M2020: $02021: $20.10M2022: $02023: $151.0K2024: $3.55M2025: $244.06M$244.06M
2019Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$244.06M+6775.0%
2024$3.55M+2251.0%
2023$151.0K—
2022$0-100.0%
2021$20.10M—
2020$0-100.0%
2019$10.00M—